Clinicopathologic heterogeneity in hypertrophic cardiomyopathy with regard to age, asymmetric septal hypertrophy, and concentric hypertrophy beyond the pediatric age group

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 5, 1998, Pages 434-441

  Litovsky, Silvio H ^a,c   Rose, Alan G ^a,b  

^a UNITED HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; FEMALE; HEART MUSCLE BIOPSY; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; SUDDEN DEATH;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HEART SEPTUM; HUMANS; HYPERTROPHY; MALE; MIDDLE AGED;

EID: 0031808701     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958;20:1-8.
2. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. (First of two parts). N Engl J Med. 1987;316:780-789.
3. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. (Second of two parts). N Engl J Med. 1987;316:844-852.
4. Louie EK, Maron BJ. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance. J Am Coll Cardiol. 1986;8:57-65.
5. McKenna WJ, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981;47:532-538.
6. Wigle ED, Rakowski H, Kimball BP, Williams WC. Hypertrophic cardio-myopathy: clinical spectrum and treatment. Circulation. 1995;92:1680-1692.
7. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation. 1994;90:2731-2742.
8. Ferrans VJ, Rodriguez ER. Specificity of light and electron microscopic features of hypertrophic obstructive and nonobstructive cardiomyopathy: qualitative, quantitative and etiologic aspects. Eur Heart J. 1983;4(suppl F):9-22.
9. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986; 8:545-557.
10. Maron BJ, Roberts WC. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation. 1979;59:689-706.
11. Olsen EGJ. The pathology of idiopathic hypertrophic subaortic stenosis (hypertrophic cardiomyopathy): a critical review. Am Heart J. 1980;100:553-562.
12. Rose AG. Evaluation of pathological criteria for diagnosis of hypertrophic cardiomyopathy. Histopathology. 1984;8:395-406.
13. Maron BJ. Myocardial disorganisation in hypertrophic cardiomyopathy: another point of view. Br Heart J. 1983;50:1-3.
14. Tanaka M. Fujiwara H, Kawai C. Pathological features of hypertrophic cardiomyopathy without asymmetrical septal hypertrophy. Br Heart J. 1986;56:294-297.
15. Tanaka M, Fujiwara H, Onodera T, Wu D, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J. 1986;55:575-581.
16. Factor SM, Butany J, Sole MJ, Wigle ED, Williams WC, Rojkind M. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1991;17:1343-1351.
17. Maron BJ, McIntosh CL, Klues HG, Cannon RO III, Roberts WC. Morphologic basis for obstruction to right ventricular outflow in hypertrophic cardiomyopathy. Am J Cardiol. 1993;71:1089-1094.
18. Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy - pathology and pathogenesis. Histopathology. 1995;26:493-500.
19. Mohr R, Schaff HV, Danielson GK, Puga FJ, Pluth JR, Tajik AJ. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy: experience over 15 years. J Thorac Cardiovasc Surg. 1989;97:666-667.
20. McKenna WJ, Sadoul N, Slade AKB, Saumarez RC. The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. Circulation. 1994;90:3115-3117.
21. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical ß-myosin heavy chain gene mutations. Circulation. 1994;89:22-32.
22. Lever HM, Karam RF, Currie PJ, Healy BP. Hypertrophic cardiomyopathy in the elderly. Circulation. 1989;79:580-589.
23. Lewis JF, Maron BJ. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol. 1989;13:36-45.
24. Lewis JF, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients 265 years of age. Am J Cardiol. 1994;73:1105-1111.
25. Chikamora T, Doi YL, Yonezawa Y, Dickie S, Ozawa T, McKenna WJ. Comparison of clinical features in patients ≥60 years of age to those ≤40 years of age with hypertrophic cardiomyopathy. Am J Cardiol. 1990;66:875-877.
26. Shapiro LM. Hypertrophic cardiomyopathy in the elderly. Br Heart J. 1990; 63:265-266. Editorial.
27. Dalldorf FG, Willis PW. Angled aorta ("sigmoid septum") as a cause of hypertrophic subaortic stenosis. Hum Pathol. 1985;16:457-462.
28. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1989;13:820-823.
29. Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation. 1992;85(suppl I);85:I-57-I-63.
30. Cannan CR, Reeder GS, Bailey KR, Melton LJ, Gersh BJ. Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990. Circulation. 1995;92:2488-2495.
31. Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation. 1992;85:1651-1660.
32. Goor D, Lillehei CW, Edwards JE. The "sigmoid septum" - variation in the contour of the left ventricular outlet. Am J Roentgenol. 1969;107:366-376.
33. Davies MJ. Hypertrophic cardiomyopathy: one disease or several? Br Heart J. 1990;63:263-264.
34. Moolman JC, Corfield VA, Posen B, et al. Sudden death due to troponin T mutations. J Am Coll Cardiol. 1997;29:549-555.
35. McKenna WJ, Stewart JT, Nihoyannopoulos P, McGinty F, Davies MJ. Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J. 1990;63:287-290.